Insulin-like growth factor-I and -II in human benign prostatic hyperplasia: Relationship with binding proteins 2 and 3 and androgens

Steroids

Volumn 63, Issue 5-6, 1998, Pages 362-366

  Monti, Salvatore ^a,b   Di Silverio, Franco ^a   Lanzara, Stefania ^a   Varasano, Paola ^a   Martini, Chiara ^a   Tosti Croce, Carlo ^a   Sciarra, Francesco ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b POLICLINICO UMBERTO I   (Italy)

Author keywords

Adrogens; BPH; IGF I; IGF II; IGFBP2; IGFBP3

Indexed keywords

ANDROGEN; ANDROSTANEDIOL; ANDROSTANOLONE; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; SYNAPSIN II; TESTOSTERONE;

ADULT; AGED; AUTOCRINE EFFECT; CLINICAL ARTICLE; CONFERENCE PAPER; CORRELATION FUNCTION; HORMONE DETERMINATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MITOGENESIS; PROSTATE HYPERTROPHY; PROTEIN BINDING; PROTEIN INTERACTION; RADIOIMMUNOASSAY; STATISTICAL ANALYSIS; TISSUE LEVEL;

AGED; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MALE; MIDDLE AGED; PROSTATIC HYPERPLASIA; TESTOSTERONE;

EID: 0032076228     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-128X(98)00034-8     Document Type: Conference Paper

References (32)

1. 1. McNeal JE (1978). Origin and evolution of benign prostatic enlargement. Invest Urol 15:340-345.
2. 2. McConnell JD (1991). The pathophysiology of benign prostate hyperplasia. J Androl 12:356-363.
3. 3. Kovacs WJ, Griffin JE, Weaver DD, Carlson BR, Wilson JD (1984). A mutation that causes lability of the androgen receptor under conditions that normally promote transformation to the DNA-binding state. J Clin Invest 73:1095-1104.
4. 4. Imperato-McGinley J, Gautier T, Zirinsky K, Hom T, Palomo O, Stein E, Vaughan ED, Markisz JA, de Arellano ER, Kazam E (1992). Prostate visualization studies in males homozygous and heterozygous for 5 alpha reductase deficiency. J Clin Endocrinol Metab 75:1022-1026.
5. 5. McKeehan WL, Adams PS, Rosser MP (1984). Direct mitogenic effects of insulin, epidermal growth factor, glucocorticoids, cholera toxin, unknown pituitary factors and possibly prolactin, but not androgens, on normal rat prostate epithelial cells in serum-free primary cell culture. Cancer Res 44:1998-2010.
6. 6. Cunha GR, Donjacour AA, Cooke PS, Mee S, Bigsby RM, Higgins SJ, Sugimura Y (1987). The endocrinology and developmental biology of the prostate Endocr Rev 8:338-362.
7. 7. Steiner MS (1993). Role of peptide growth factors in the prostate: A review. Urology 42:99-110.
8. 8. Griffiths K, Akaza H, Eaton CL, El Etreby M, Habib F, Lee C, Partin AW, Coffey DS, Sciarra F, Steiner G, Tenniswood MP (1993). Regulation of prostatic growth. In: Cockett ATK, Khoury S, Aso Y, Chatelain C, Denis L, Griffiths K, Murphy G (eds), Proceedings of the "2nd International Consultation on Benign Prostatic Hyperplasia (BPH). SCI, Paris, pp. 49-75.
9. 9. Jones JI, Clemmons DR (1995). Insulin-Like Growth Factors and their binding proteins: biologic actions. Endor Rev 16:3-34.
10. 10. Neely EK, Beukers MW, Oh Y, Cohen P, Rosenfeld RG (1991). Insulin-like growth factor receptors. Acta Pediatr Scand (Suppl.) 372:116-123.
11. 11. Fiorelli G, De Bellis A, Longo A, Giannini S, Natali A, Costantini A, Vannelli GB, Serio M (1991). Insulin-like Growth factor-I receptors in human hyperplastic prostate tissue: Characterization, tissue localization, and their modulation by chronic treatment with a gonadotropin-releasing hormone analog. J Clin Endocrinol Metab 72:740-746.
12. 12. Monti S, Sciarra F, Adamo MV, Toscano V, Trotta MC, Martini C, Lanzara S, Di Silverio F (1997). Prevalent decrease of the EGF content in the periurethral zone of BPH tissue induced by treatment with finasteride or flutamide. J Androl 17:488-494.
13. 13. Bang P (1995). Valid measurements of total IGF concentrations in biologic fluids: Recommendations from the 3rd International Symposium on Insulin-like Growth Factors. Eur J Endocr 132:338-339.
14. 14. Cullen KJ, Lippman ME, Chow D, Hill S, Rosen Neal, Zwiebel JA (1992). Insulin-like growth factor-II overexpression in MCF-7 cells induces phenotypic changes associated with malignant progression. Mol Endocr 6:91-100.
15. 15. Mohan S, Bautista CM, Herring SJ, Linkhart TA, Baylink DJ (1990). Development of valid methods to measure insulin-like growth factors-I and -II in bone cell-conditioned medium. Endocrinology 126:2534-2542.
16. 16. Toscano V, Petrangeli E, Adamo MV, Foli S, Caiola S, Sciarra F (1981). Simultaneous determination of 5α-reduced metabolites of testosterone in human plasma. J Steroid Biochem 14:574-578.
17. 17. Sciarra F, Monti S, Adamo MV, Palma E, Toscano V, d'Eramo G, Di Silverio F (1995). Regional distribution of epidermal growth factor, testosterone and dihydrotestosterone in benign prostatic hyperplasia tissue. Urol Res 23:387-390.
18. 18. Cohen P, Peehl DM, Lamson G, Rosenfeld RG (1991). Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins in primary cultures of prostate epithelial cells. J Clin Endocrinol Metab 73:401-407.
19. 19. Bonnet P, Reiter E, Bruyninx M, Sente B, Dombrowicz D, de Leval J, Closset J, Hennen G (1993). Benign prostatic hyperplasia and normal prostate aging: Differences in type I and II 5 alpha reductase and steroid hormone receptor messenger ribonucleic acid (mRNA) levels, but not in insulin-like growth factor mRNA levels. J Clin Endocrinol Metab 77:1203-1208.
20. 20. Dong G, Rajah R, Vu T, Hoffman AR, Ronsenfeld RG, Roberts CT, Peehl DM, Cohen P (1997). Decreased expression of Wilms' tumor gene WT-1 and elavated expression of insulin growth factor-II (IGF-II) and type 1 IGF receptor genes in prostatic stromal cells from patients with benign prostatic hyperplasia. J Clin Endocrinol Metab 82:2198-2203.
21. 21. Boudon C, Rodier G, Lechevallier E, Mottet N, Barenton B, Sultan Ch (1996). Secretion of insulin-like growth factors and their binding proteins by human normal and hyperplastic prostatic cells in primary culture. J Clin Endocrinol Metab 81:612-617.
22. 22. Barni T, Vannelli BG, Sadri R, Pupilli C, Ghiandi P, Rizzo M, Selli C, Serio M, Fiorelli G (1994). Insulin-Like Growth Factor-I (IFG-I) and its Binding Protein IGFBP-4 in human prostatic hyperplastic tissue: gene expression its cellular localization. J Clin Endocrinol Metab 78:778-783.
23. 23. Horton R, Pasupuletti V, Antonipillai I (1993). Androgen induction of steroid 5 alpha reductase may be mediated via insulin-like growth factor-I Endocrinology 133:447-451.
24. 24. Toscano V (1986). Dihydrotestosterone metabolism Clin Endocrinol Metab 15: 279-292.
25. 25. Walsh PG, Wilson JD (1976). The induction of prostatic hypertrophy in the dog with androstanediol. J Clin Invest 57:1093-1097.
26. 26. Nakhla A M, Ding VDH, Khan MS, Nicholas AR, Rhodes L, Smith RG, Rosner W (1995). 5α-androstan-3α,17β-diol is a hormone: stimulation of cAMP accumulation in human and dog prostate. J Clin Endocrinol Metab 80:2259-2262.
27. 27. Farnsworth WE (1996). Roles of estrogen and SHBG in prostate physiology. Prostate 28:17-23.
28. 28. D'Ercole AJ, Stiles AD, Underwood LE (1984). Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. Proc Natl Acad Sci USA 81:935-939.
29. 29. Lubrano C, Toscano V, Petrangeli E, Spera G, Trotta MC, Rombola' N, Frati L, Di Silverio F, Sciarra F (1993). Relationship between epidermal growth factor and its receptor in human benign prostatic hyperplasia. J Steroid Biochem Mol Biol 46:463-468.
30. 30. Oh Y, M 129 ller HL, Pham H, Rosenfeld RG (1993). Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells. J Biol Chem 268:26045-26048.
31. 31. Conover CA (1990). Regulation of insulin-like growth factor (IGF)-binding protein synthesis by insulin and IGF-I in cultured bovine fibroblasts. Endocrinology 126:3139-3145.
32. 32. Cohen P, Graves HCB, Peehl DM, Kamarei M, Giudice LC, Rosenfeld RG (1992). Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma. J Clin Endocrinol Metab 75:1046-1053.